Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, quadruple blinded, phase II treatment trial (Parallel Assignment) evaluating Metoclopramide in patients with Diabetic gastroparesis
Primary outcome measures
Change From Baseline to Week 4 of the Treatment Period in the Modified Gastroparesis Cardinal Symptom Index-Daily Diary (mGCSI-DD) Total Score.
Conclusion
Metoclopramide nasal spray was found by the authors to alleviate symptoms of gastroparesis in women with diabetes, but not in men. Consequently, patient sex could be an important factor when choosing a treatment for [diabetic gastroparesis](brain://U5ZFD7SRpkOH6M79xrOx6Q/DiabeticGa…